Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Chembio Diagnostics Inc (NASDAQ:CEMI)

5.12
Delayed Data
As of 3:59pm ET
 0.00 / 0.00%
Today’s Change
3.04
Today|||52-Week Range
5.25
+30.95%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$49.3M

Company Description

Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. Its main products presently commercially available are four rapid tests for the detection of HIV antibodies. The company sells its products under its STAT PAK, SURE CHECK, DPP and SampleTainer trademarks. The company's business roots back to 1985. Chembio Diagnostics was founded on May 5, 2004 and is headquartered in Medford, NY.

Contact Information

Chembio Diagnostics, Inc.
3661 Horseblock Road
Medford New York 11763
P:(631) 924-1135
Investor Relations:
16319241135125

Employees

Shareholders

Mutual fund holders2.84%
Other institutional16.80%
Individual stakeholders11.95%

Top Executives

John J. SperzelPresident, Chief Executive Officer & Director
Sharon KlugewiczChief Operating Officer
Richard J. LarkinChief Financial Officer
Javan EsfandiariChief Science & Technology Officer
Richard BruceVice President-Operations